SCHEMBL13428362

SCHEMBL13428362

c1ccc2c(c1)Sc1ccccc1N2c1cccc2c(-c3cccc4ccccc34)c3c(N4c5ccccc5Sc5ccccc54)cccc3c(-c3cccc4ccccc34)c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 7/20 0.45
SLC6A3 Q01959 1/20 0.45
POLB P06746 1/20 0.41
ACHE P22303 1/20 0.38
MAOA P21397 1/20 0.37
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
KDM4E B2RXH2 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
HIF1A Q16665 1/20 0.35
TYMS P04818 1/20 0.34
ALDH1A1 P00352 2/20 0.34
DHFR P00374 1/20 0.34
HPGD P15428 2/20 0.33
TYMP P19971 1/20 0.33
LMNA P02545 1/20 0.33
HSD17B10 Q99714 1/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13540283 0.82 BCHE (0.35) BCHESLC6A3ACHE
SCHEMBL18770793 0.80 BCHE (0.54) BCHESLC6A3POLBACHEMAOA
SCHEMBL30286094 0.80 BCHE (0.54) BCHESLC6A3POLBACHEMAOA
SCHEMBL13008476 0.80 POLB (0.42) POLBCYP2D6CYP2C19KDM4ECYP1A2
SCHEMBL13008474 0.80 MAOA (0.40) BCHESLC6A3ACHEMAOAKDM4E
SCHEMBL13428344 0.79 POLB (0.41) POLBKDM4EMAPTTYMSALDH1A1
SCHEMBL13428341 0.79 POLB (0.41) POLBCYP2D6CYP2C19KDM4ECYP1A2
SCHEMBL13428343 0.78 BCHE (0.42) BCHESLC6A3ACHEMAOACYP2D6
SCHEMBL13427120 0.77 BCHE (0.41) BCHESLC6A3POLBACHEMAOA
SCHEMBL13408867 0.77 BCHE (0.41) BCHESLC6A3POLBACHEMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051106-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same RPL36, RPL39, RPL36A BCHE 3337/4885SLC6A3 2644/4885POLB 913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.